[Levothyroxine therapy compliance. What can we do to improve it?]
Aten Primaria
.
2012 Jul;44(7):438-9.
doi: 10.1016/j.aprim.2010.11.009.
Epub 2012 Apr 30.
[Article in Spanish]
Authors
Rosa López-Torres Hidalgo
,
Jose Antonio Carbajal de Lara
;
Grupo de Investigación del Colegio Oficial de Farmacéuticos de Albacete (GICOFAB)
Collaborators
Grupo de Investigación del Colegio Oficial de Farmacéuticos de Albacete (GICOFAB)
:
Rosa López-Torres Hidalgo
,
Fernando Honrubia Alujer
,
Pedro Merino Campos
,
Beatriz Cuéllar Bolás
,
Pablo Silvestre Molina
,
Elena Quijano Triviño
,
José Antonio Carbajal de Lara
,
Eduardo Giménez Benítez
,
Teresa Cano Verdejo
,
Emilia Andrés Cifuentes
,
Ana Pastor Pons
PMID:
22551624
PMCID:
PMC7025255
DOI:
10.1016/j.aprim.2010.11.009
No abstract available
Publication types
Letter
MeSH terms
Adult
Female
Humans
Hypothyroidism / drug therapy*
Male
Medication Adherence / statistics & numerical data*
Middle Aged
Thyroxine / therapeutic use*
Substances
Thyroxine